Methods comprising apoptosis inhibitors for the generation of transgenic pigs |
 |
|
|
||||||||||||||||||||||||||||||||||||||||||
| Title: | Human mesenchymal stem cells |
| Inventors: | Davis-Sproul, Janice M.; Towson, MD, USA Moorman, Mark Aaron; Baltimore, MD, USA McNeil, Renee Marie; Baltimore, MD, USA Simonetti, Jr., Donald William; Forest Hill, MD, USA Hammill, Lora Catherine; Bel Air, MD, USA Craig, Stewart; Timonium, MD, USA |
| Summary: | Described herein are human mesenchymal stem cells, methods and uses thereof. The invention relates to human mesenchymal stem cells having the phenotypes SH3+ and CD45+, and methods of their isolation and delivery. Therapeutic applications of such precursor mesenchymal cells are included, such as in the treatment of mensenchymal stem cell-deficient patients. |
| Abstract: | Human mesenchymal stem cells having the phenotype SH3+, CD45+ can be isolated. These precursor mesenchymal item cells are useful for treatment of patients in need of mensenchymal stem cell. |
| US Patent Website: | Click Here for Full Text of Patent |
| Title Number: | US6387367 |
| Application Number: | US1999000321924 |
| Date Filed: | 28/05/1999 |
| Date Published: | 14/05/2002 |
| Assignee: | Osiris Therapeutics, Inc., Baltimore, MD, USA |